MedTrace Logo

Intravenous Remifentanil Plus Morphine or Morphine Alone for Postthoracotomy Pain

NCT01830296 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2013-04-12

No results posted yet for this study

Summary

Background; Post-thoracotomy pain remains a major problem. This double-blind, randomized study tested the effects of coadministration of patient controlled remifentanil+morphine combination on postthoracotomy pain, analgesic consumption and side effects compared with morphine PCA alone

Conditions

Interventions

DRUG

Remifentanil+morphine

Morphine, Remifentanil+Morphine

Sponsors & Collaborators

  • Cukurova University

    lead OTHER

Principal Investigators

  • Mediha Turktan, Assist Prof · Cukurova University, Department of Anaesthesiology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
59 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2012-10-31
Completion
2012-12-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01830296 on ClinicalTrials.gov